Clarifications regarding the 3' repeat region of the cagA gene in Helicobacter pylori and clinical outcome.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. CagA of Helicobacter pylori interacts with and inhibits the serine-threonine kinase PRK2.Cellular microbiology · 2015
   Article
2. Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains.Internal medicine (Tokyo, Japan) · 2008
   Review
3. A new subtype of 3' region of cagA gene in Helicobacter pylori strains isolated from Zhejiang Province in China.World journal of gastroenterology · 2004
   Article

Corrections and comments

• Comment on
  Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases.1998
• Comment on
  Consensus and variable region PCR analysis of Helicobacter pylori 3' region of cagA gene in isolates from individuals with or without peptic ulcer.2001

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as